Skip to content

Home-Based Exercise for Adults Living With Overweight and Obesity

WE Are Active and In This toGetHer (WEIGH): a Randomised Controlled Trial to Ascertain the Feasibility of a Home-based Exercise Programme for People Living With Overweight and Obesity

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05807386
Acronym
WEIGH
Enrollment
30
Registered
2023-04-11
Start date
2025-01-31
Completion date
2027-06-30
Last updated
2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

home-based exercise

Brief summary

The study aims to implement a 12-week home-based exercise programme utilising an online intervention delivery platform. The focus will be on increasing exercise behaviour within the participant's home setting using aerobic, resistance and flexibility exercises as well as behaviour change techniques. Following the programme, semi-structured interviews will be conducted, to explore participant experiences. It is hypothesised that the exercise programme will be feasible, accessible and acceptable.

Interventions

BEHAVIORALHome-based exercise programme

A 12 week, online delivered, home-based exercise programme.

Sponsors

Coventry University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* BMI ≥25kg/m² or BMI ≥30kg/m² * English speaking * Able to follow visual and verbal instructions * Access to the internet and accompanying technology (e.g. laptop or tablet) * Physically able to undertake aerobic, resistance and flexibility exercise

Exclusion criteria

* Unable to provide informed consent * Receiving invasive medical treatment or planned surgery preceding to, or during, the programme * Severe mental or physical limitations precluding participation safely in the home environment * No access to the internet and/or facilitative technology such as a laptop or tablet * Pregnancy * Current smoker or vaping. * Currently or very recently stopped taking weight loss medication (within the last two weeks) * Recently experienced substantial weight change (defined as 5% within 6-12 months) * Presence of contraindications to exercise * Pacemaker and/or other implanted metal device * At high risk of cardiovascular event

Design outcomes

Primary

MeasureTime frameDescription
Feasibility and acceptability of the programme through recruitment rateCalculated at trial end, i.e.12 weeks after inclusion.Recruitment rate will be calculated by dividing the number of eligible candidates by the number who consent to participate.
Acceptability and experience of the programme via participant interviewsEvaluated after intervention period, i.e. up to 12 weeks after inclusion offer.Interviews will take place between the researcher and participant to explore their experience on the programme and identifying areas for improvement. This may be with participants who completed the intervention, withdrew or declined to participate.
Feasibility and acceptability of the programme through completion rateCalculated at trial end, i.e. 12 weeks after inclusion.Completion rate will be calculated by dividing the number of participants who successfully complete the programme, by the number of participants that attempt.
Feasibility and acceptability of the programme through intervention engagementCalculated at trial end, i.e. 12 weeks after inclusion.Engagement will be calculated by monitoring participant's activity on the online platform.
Feasibility and acceptability of the programme through adherenceCalculated at trial end, i.e. 12 weeks after inclusion.Adherence will calculated by monitoring the online platform engagement and outputs from post exercise session questionnaires.
Feasibility and acceptability of the programme through attritionCalculated at trial end, i.e. 12 weeks after inclusion.Attrition rate will be defined and calculated as discontinuation of the intervention without return.

Secondary

MeasureTime frameDescription
Participant resting blood pressure (mmHg)Taken at baseline, 6 weeks and 12 weeks/programme completion.Resting diastolic and systolic blood pressure (mmHg) will be taken using a blood pressure monitor.
Participant Body Mass (kg)Taken at baseline, 6 weeks and 12 weeks/programme completion.Participant Body Mass will be measured using calibrated, digital scales.
Participant Body Fat Mass (kg)Taken at baseline, 6 weeks and 12 weeks/programme completion.Participant Body Fat Mass will be measured using the BiodyXpertZMII.
Participant Body Fat Percentage (%)Taken at baseline, 6 weeks and 12 weeks/programme completion.Participant Body Fat Percentage will be measured using the BiodyXpertZMII.
Participant Fat Free Mass (%)Taken at baseline, 6 weeks and 12 weeks/programme completion.Participant Fat Free Mass will be measured using the BiodyXpertZMII.
Participant Body Mass Index (kg/m^2)Taken at baseline, 6 weeks and 12 weeks/programme completion.BMI will be calculated from combining body mass (kg) and participant height (cm).
Participant waist to hip ratioTaken at baseline, 6 weeks and 12 weeks/programme completion.Waist to hip ratio will be calculated from combining measures of waist circumference (cm) and hip circumference (cm).

Other

MeasureTime frameDescription
Functional Ability (aerobic capacity and endurance) change through Six Minute Walk testTaken at baseline and 12 weeks/programme completion.This will be measured using the Six Minute Walk test and change will be compared within and between participants.
Exercise FeelingThree/four times weekly, throughout the 12 week programme, after each exercise session is complete.Exercise feeling will be recorded using the Feeling Scale, that ranges from -5 to +5, where -5 indicates feeling 'Very Bad' and +5 indicates feeling 'Very Good'.
Exercise IntensityThree/four times weekly, throughout the 12 week programme, after each exercise session is complete.Exercise intensity will be recorded using the Borg Category Ratio (CR-10) scale, and change will be compared to the prescribed programme intensity. Higher scores are associated with a higher exercise intensity.
Physical ActivityTaken at baseline, 6 weeks and 12 weeks/programme completion.This will be measured using the International Physical Activity Questionnaire - Long Form (IPAQ-LF), and change will be compared within and between participants. Scores may be categorised and/or sub scores calculated for each domain where higher scores are associated with better physical activity behaviour.
Quality of Life and Cost EffectivenessTaken at baseline, 6 weeks and 12 weeks/programme completion.This will be measured using the European Quality of Life Five Dimension Questionnaire (EQ-5D-5L), and change will be compared within and between participants. Scores range from 1-5 with lower scores associated with a better outcome.
Functional Ability (strength) change through hand grip strength testTaken at baseline and 12 weeks/programme completion.This will be measured using the hand grip dynamometer, and change will be compared within and between participants.
Functional Ability (leg strength and endurance) change through 30s Sit to Stand testTaken at baseline and 12 weeks/programme completion.This will be measured using the 30s Sit to Stand test and change will be compared within and between participants.

Contacts

Primary ContactSofie Power
powers3@coventry.ac.uk
Backup ContactProf. David Broom
ad5173@coventry.ac.uk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026